Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics publishing date : 2021 - 11 - 12 save search
Akero Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
Published: 2021-11-12 (Crawled : 00:20) - ir.akerotx.com
AKRO | $20.51 -5.05% -5.19% 560K
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
financial results results
Celularity Reports Third Quarter 2021 Financial Results and Corporate Update
Published: 2021-11-12 (Crawled : 00:20) - globenewswire.com
ONCT | News | $8.6 -3.91% -1.82% 2.8K
|
Health Technology
| Email alert
Add to watchlist
CELU | News F | $3.21 -3.02% -4.42% 42K
|
| Email alert
Add to watchlist
financial results results
Jasper Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
JSPR | $23.21 -2.56% -2.32% 120K
|
|
| O: -0.36%
H: 4.43%
C: 1.44%
AVRO | $1.24 1.64% 0.81% 37K
|
Health Technology
|
| O: 0.37%
H: 8.41%
C: -0.93%
financial results results
AgeX Therapeutics Reports Third Quarter 2021 Financial Results
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
AGE A | $11.1 0.0% 3.8K
|
Health Technology
|
| O: -2.27%
H: 2.49%
C: 1.25%
financial results results therapeutics
Xilio Therapeutics Announces Preclinical Data Demonstrating Anti-Tumor Activity and Tolerability of XTX301, a Tumor-Selective IL-12, at Society for Immunotherapy in Cancer Annual Meeting
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
XLO | $1.28 4.06% 0.0% 130K
|
Professional, Scientific, and T...
|
| O: -3.14%
H: 0.07%
C: -3.67%
preclinical immunotherapy therapy cancer pre-clinical
Aimmune Therapeutics Presents New PALFORZIA® [Peanut (Arachis hypogaea) Allergen Powder-dnfp] Data on Immunological Outcomes of Long-Term Daily Oral Immunotherapy at the EAACI PAAM Digital Meeting
Published: 2021-11-12 (Crawled : 22:00) - biospace.com/
IMUN | $0.093 214.52% 1.8K
|
Manufacturing
|
| O: 8.62%
H: 0.0%
C: -1.59%
immunotherapy therapy
Sorrento Therapeutics Mexico to Partner with the World Boxing Council for the Screening of COVID-19 of all Convention Attendees with COVI-STIX at the 59th World Boxing Council Convention in Mexico City
Published: 2021-11-12 (Crawled : 21:00) - globenewswire.com
SRNE | $0.024 -14.29% -8.85% 57K
|
Health Technology
| Email alert
Add to watchlist
covid
New Real-World Data Show High Rate of Patient Adherence to TEPEZZA® (teprotumumab-trbw) for Thyroid Eye Disease (TED)
Published: 2021-11-12 (Crawled : 18:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: 0.0%
disease eye eye disease
Sorrento Announces Publication of Significant Positive Pivotal Trial Results of Abivertinib for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in the Peer-Reviewed Journal Clinical Cancer Research
Published: 2021-11-12 (Crawled : 15:00) - globenewswire.com
SRNE | $0.024 -14.29% -8.85% 57K
|
Health Technology
|
| O: 1.34%
H: 0.0%
C: 0.0%
treatment lung cancer positive results cancer research trial trial results
Rapid Therapeutic Science Laboratories to Present at the Q4 Investor Summit Conference
Published: 2021-11-12 (Crawled : 15:00) - globenewswire.com
RTSL | $0.005 11.77% 130K
|
Manufacturing
|
| O: 3.7%
H: 0.0%
C: 0.0%
q4 conference
Capricor’s CEO Dr. Linda Marbán to Serve as Keynote Speaker at TriLink Annual mRNA Day
Published: 2021-11-12 (Crawled : 15:00) - globenewswire.com
CAPR | $5.05 -9.01% -9.79% 940K
|
Health Technology
|
| O: -0.58%
H: 0.0%
C: 0.0%
ceo
Avenue Therapeutics Announces Closing of Public Offering of Common Stock
Published: 2021-11-12 (Crawled : 15:00) - globenewswire.com
FBIO | $1.81 2.26% 2.21% 440K
|
Health Technology
|
| O: 3.78%
H: 0.0%
C: 0.0%
ATXI | $0.1346 -0.37% -3.05% 300K
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: 0.0%
offering therapeutics publication
Compass Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-11-12 (Crawled : 14:30) - biospace.com/
CMPX | $1.49 -2.61% -2.0% 170K
|
Professional, Scientific, and T...
|
| O: 0.84%
H: 1.93%
C: -1.93%
financial results results
BriaCell Announces Update on Previously Announced Securities Buyback Program and Participation at Upcoming Conferences
Published: 2021-11-12 (Crawled : 14:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 4.3%
H: 0.0%
C: 0.0%
conference
Dermata Announces Presentation Details for Its DMT410 Phase 1b Proof of Concept Aesthetic Study at The American Society for Dermatologic Surgery (ASDS) 2021 Annual Meeting
Published: 2021-11-12 (Crawled : 14:00) - biospace.com/
DRMA | $0.3382 14.68% 11.07% 280K
|
|
| O: 5.02%
H: 0.0%
C: 0.0%
presentation phase 1 aesthetic proof of concept phase 1b phase 2b lsd
Immune Analysis from Phase 2 Triple Negative Breast Cancer Trial Demonstrates Trilaciclib Enhanced Patients’ T Cell Immune Function When Administered Prior to Chemotherapy
Published: 2021-11-12 (Crawled : 14:00) - biospace.com/
GTHX | $4.17 -2.57% -2.88% 660K
|
Health Technology
|
| O: 3.14%
H: 0.0%
C: 0.0%
phase 2 therapy cancer breast cancer trial trilaciclib t-cell
Aditxt Provides an Update Regarding its Target Acquisition AiPharma Global Holdings LLC
Published: 2021-11-12 (Crawled : 14:00) - biospace.com/
ADTX | $2.41 2.55% 0.84% 55K
|
Health Technology
|
| O: -35.64%
H: 0.0%
C: 0.0%
acquisition
Prelude Therapeutics Announces Third Quarter 2021 Financial Results and Operations Update
Published: 2021-11-12 (Crawled : 14:00) - globenewswire.com
PRLD | $3.44 -17.7% -21.51% 110K
|
Health Technology
|
| O: -1.48%
H: 0.0%
C: 0.0%
financial results results
Ankyra Therapeutics Announces $45 Million Series B Financing and Appoints Howard L. Kaufman M.D. as Chief Medical Officer
Published: 2021-11-12 (Crawled : 14:00) - biospace.com/
REPL | $6.97 -3.33% -3.3% 1.1M
|
Health Technology
|
| O: 1.01%
H: 0.0%
C: 0.0%
Aptevo Therapeutics Reports Third Quarter Financial Results With Business Highlights
Published: 2021-11-12 (Crawled : 14:00) - biospace.com/
APVO 3 d | $0.77 8.07% 6.25% 210K
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
financial results results therapeutics
Gainers vs Losers
| 60% | 40% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.